Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2011

Published : November 2011
No. of Pages : 36

Price:

Summary

Global Markets Direct’s, 'Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2011', provides an overview of the Acquired (Autoimmune) Hemolytic Anemia therapeutic pipeline. This report provides information on the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia. 'Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Acquired (Autoimmune) Hemolytic Anemia.
- A review of the Acquired (Autoimmune) Hemolytic Anemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Acquired (Autoimmune) Hemolytic Anemia pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Acquired (Autoimmune) Hemolytic Anemia.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Acquired (Autoimmune) Hemolytic Anemia pipeline depth and focus of Acquired (Autoimmune) Hemolytic Anemia therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Acquired (Autoimmune) Hemolytic Anemia Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Acquired (Autoimmune) Hemolytic Anemia 7
Acquired (Autoimmune) Hemolytic Anemia Therapeutics under Development by Companies 9
Acquired (Autoimmune) Hemolytic Anemia Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Acquired (Autoimmune) Hemolytic Anemia Therapeutics - Products under Development by Companies 14
Acquired (Autoimmune) Hemolytic Anemia Therapeutics - Products under Investigation by Universities/Institutes 15
Companies Involved in Acquired (Autoimmune) Hemolytic Anemia Therapeutics Development 16
Accentia Biopharmaceuticals, Inc. 16
Acquired (Autoimmune) Hemolytic Anemia - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Combination Products 18
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Drug Profiles 23
Revimmune - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Cyclophosphamide + Filgrastim - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Mabthera - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Prednisolone + Mabthera - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Rituximab + Prednisone - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Acquired (Autoimmune) Hemolytic Anemia Therapeutics – Drug Profile Updates 29
Acquired (Autoimmune) Hemolytic Anemia - Featured News 30
Jun 23, 2011: FDA Grants Orphan Drug Status For Accentia's Revimmune Therapy In Systemic Sclerosis And Hemolytic Anemia 30
Jun 11, 2011: Alexion Presents Additional Data At EHA Congress Describing Long-Term Efficacy And Survival Data With Sustained Soliris Therapy 30
May 23, 2011: Researchers To Present Nine Studies On Alexion's Soliris In Patients With PNH And aHUS At EHA Congress 31
Feb 28, 2007: Accentia Biopharmaceuticals Acquires Worldwide Exclusive License To Revimmune 33
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 36
Contact Us 36
Disclaimer 36

List of Tables
Number of Products Under Development for Acquired (Autoimmune) Hemolytic Anemia, H2 2011 7
Products under Development for Acquired (Autoimmune) Hemolytic Anemia – Comparative Analysis, H2 2011 8
Number of Products under Development by Companies, H2 2011 9
Number of Products under Investigation by Universities/Institutes, H2 2011 10
Comparative Analysis by Late Stage Development, H2 2011 11
Comparative Analysis by Mid Clinical Stage Development, H2 2011 12
Comparative Analysis by Pre-Clinical Stage Development, H2 2011 13
Products under Development by Companies, H2 2011 14
Products under Investigation by Universities/Institutes, H2 2011 15
Accentia Biopharmaceuticals, Inc., H2 2011 16
Assessment by Monotherapy Products, H2 2011 17
Assessment by Combination Products 18
Assessment by Stage and Route of Administration, H2 2011 20
Assessment by Molecule Type, H2 2011 22
Acquired (Autoimmune) Hemolytic Anemia Therapeutics – Drug Profile Updates 29

List of Figures
Number of Products under Development for Acquired (Autoimmune) Hemolytic Anemia, H2 2011 7
Products under Development for Acquired (Autoimmune) Hemolytic Anemia – Comparative Analysis, H2 2011 8
Products under Development by Companies, H2 2011 9
Products under Investigation by Universities/Institutes, H2 2011 10
Late Stage Products, H2 2011 11
Mid Clinical Stage Products, H2 2011 12
Pre-Clinical Stage Products, H2 2011 13
Assessment by Monotherapy Products, H2 2011 17
Assessment by Combination Products, H2 2011 18
Assessment by Route of Administration, H2 2011 19
Assessment by Stage and Route of Administration, H2 2011 20
Assessment by Molecule Type, H2 2011 21
Assessment by Stage and Molecule Type, H2 2011 22

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2011

Published By: Global Markets Direct

Price:

How to Purchase

Purchase products from our site in 5 easy steps. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .

sales@marketreportsonline.com + 1 888 391 5441

Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option

Get Email alerts about market research reports from industries and publishers of your interest: